New York, United States, Dec. 06, 2022 (GLOBE NEWSWIRE) -- A hemodialysis is a form of treatment used to remove water and waste from the blood. During kidney failure, dialysis removes wastes such as urea and creatinine as well as free water from the blood. According to the 2017 National Chronic Kidney Disease Fact Sheet, approximately 15% of the adult population of the United States is estimated to have chronic kidney diseases. Diabetes and cardiovascular illness are the leading causes of kidney disease. Thus, it is anticipated that the increasing prevalence of diabetes and hypertension will contribute to the growing popularity of hemodialysis. According to the National Kidney Foundation, approximately ten percent of the world's population is affected by chronic kidney disease (CKD), and millions die annually due to a lack of affordable treatment.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/hemodialysis-market/request-sample
Rising Prevalence of Kidney Failure and Diabetes
Diabetes is a chronic disease that takes place when adequate insulin is not produced by the pancreas or when the body cannot utilize the insulin it does produce. Insulin is a hormone that regulates glucose levels in the blood. Hyperglycemia, which is also called high blood glucose or high blood sugar, is a common complication of uncontrolled diabetes and, over time, causes severe damage to a number of body systems, especially the nerves and blood vessels. In 2014, 8.5% of adults aged 18 and older had diabetes. In 2019, 1.5 million deaths were directly attributable to diabetes, with 48 percent of all diabetes-related deaths occurring before age 70. Diabetes caused an additional 460 000 deaths due to kidney disease. 37.3 million Americans, or roughly one in ten, have diabetes. More than one-third of adult Americans, or 96 million, have prediabetes. The increasing prevalence of kidney failure will increase the market for hemodialysis.
Innovations and Collaborations gives Opportunity for Exponential Growth
It is anticipated that the key players' adoption of strategies such as collaborations, mergers, and new innovations will propel the global hemodialysis market. Baxter Healthcare Corporation, a manufacturer of medical devices, collaborated with the non-profit Mayo Clinic in October 2018 to establish a renal care center in Florida, United States. The establishment of the center is for the benefit of patients with kidney failure and for the evaluation of new products, including hemodialysis machines. This may result in greater adoption of hemodialysis machines by healthcare institutions, thereby driving the global hemodialysis market. In addition, Baxter Healthcare Corporation launched HDx with Theranova (dialyzer) in October 2016, a hemodialysis machine used to treat end-stage renal disease. Baxter Healthcare Corporation reports that the dialysis machine is highly effective and functionally comparable to the body's natural kidneys. It can filter medium-sized molecules as well as smaller molecules effectively. Consequently, it is anticipated that this factor will stimulate the growth of the global hemodialysis market.
Report Scope
Report Metric | Details |
Market Size | USD 136.84 Billion by 2031 |
CAGR | 4.8% (2023-2031) |
Historical Data | 2020-2021 |
Base Year | 2022 |
Forecast Period | 2023–2031 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Product, End User |
Geographies Covered | North America, Europe, Asia-Pacific, LAME and Rest of the World |
Key Companies Profiled/Vendors | Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International, Inc., Cantel Medical Corp., DaVita, Inc., Diaverum, Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation, and NxStage Medical, Inc. Gambro, Satellite Healthcare, Inc., and MEDIVATORS, Inc., |
Key Market Opportunities | Increasing Collaborations and Innovations |
Key Market Drivers | Increasing Prevalence of Diabetes and Kidney Failure Increasing Geriatric Population |
Buy Now Full Report @ https://straitsresearch.com/buy-now/hemodialysis-market
Regional Analysis
North America is the most significant shareholder in the global Hemodialysis market and is anticipated to grow at a CAGR of 4.5% during the forecast period. The increased proportion is attributable to the rising prevalence of diabetes and advanced kidney disease in the region. According to the National Kidney Foundation, over 661,000 Americans have suffered from kidney failure, out of which approximately 468,000 are on regular dialysis, and 193,000 have a kidney transplant. According to the projections from the Centers for Disease Control and Prevention, 37 million American adults will have chronic kidney disease (CKD) in 2019. This represents 15 percent of the adult population or one in seven adults.
Europe is anticipated to be the second-largest hemodialysis market region. The rising prevalence of diabetes and cardiovascular disease is a major factor in the rising incidences of kidney failure. According to the British Heart Foundation, between 2014 and 2016, over 66,000 people died in the United Kingdom due to coronary heart disease. By 2040, chronic kidney disease (CKD) is expected to be the 5thleading cause of death in Europe, where it currently affects 100 million people. CKD is also one of the most expensive diseases for healthcare systems, costing an estimated EUR 140 billion annually in Europe. In addition, changing eating habits and an unhealthy lifestyle are anticipated to fuel market expansion in the coming years.
Asia-Pacific is anticipated to experience the highest growth rate in the hemodialysis market. In developing nations such as India, China, and Japan, treatment with dialysis or a kidney transplant imposes a significant financial burden. Government funding for kidney transplants is anticipated to further stimulate market expansion. Rashtriya Swasthya Bima Yojana (RSBY), which is funded by the Indian government, offers free hemodialysis to RSBY-registered BPL (below poverty line) families.
The hemodialysis market is projected to grow steadily in the LAMEA region. Hemodialysis treatment is expensive, and rising per capita income, and kidney disease awareness are anticipated to drive regional market growth.
Key Highlights
- The global hemodialysis market size was valued at USD 89.85 billion in 2022. It is projected to reach USD 136.84 billion by 2031, growing at a CAGR of 4.8% during the forecast period (2023-2031).
- Based on type, the global hemodialysis market is bifurcated into conventional, daily, and nocturnal. The conventional segment is the highest contributor to the market and is anticipated to grow at a CAGR of 4.6% during the forecast period.
- Based on product, the global hemodialysis market is bifurcated into equipment, service, consumables, and drug. The service segment is the highest contributor to the market and is anticipated to grow at a CAGR of 4.3% throughout the forecast period.
- Based on end-user, the global hemodialysis market is bifurcated into hospital-based dialysis and home dialysis. The hospital-based segment is the highest contributor to the market and is anticipated to grow at a CAGR of 4.1% throughout the forecast period.
- North America is the most significant shareholder in the global Hemodialysis market and is anticipated to grow at a CAGR of 4.5% throughout the forecast period.
The global hemodialysis market's major key players are
- Asahi Kasei Corporation
- B. Braun Melsungen AG
- Baxter International Inc.
- Cantel Medical Corp.
- DaVita Inc.
- Diaverum
- Fresenius Medical Care AG & Co. KGaA
- Nikkiso Co.Ltd.
- NxStage Medical Inc.
- Gambro
- Satellite Healthcare Inc.
- Nipro Medical Corporation
- NextKidney
- MEDIVATORS Inc.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/hemodialysis-market/request-sample
Global Hemodialysis Market: Segmentation
By Type
- Conventional
- Daily
- Nocturnal
By Product
- Priced Equipment
- Service
- Consumable
- Drug
By End User
- Hospital-Based Dialysis
- Home Dialysis
By Regions
- North America
- Europe
- Asia-Pacific
- LAMEA
TABLE OF CONTENT
- Introduction
- Market Definition
- Market Scope
- Research Methodology
- Primary Research
- Research Methodology
- Assumptions & Exclusions
- Secondary Data Sources
- Market Overview
- Report Segmentation & Scope
- Value Chain Analysis: Hemodialysis Market
- Key Market Trends
- Drivers
- Restraints
- Opportunities
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitution
- Threat of New Entrants
- Competitive Rivalry
- Market Share Analysis
- Type Overview
- Introduction
- Market Size & Forecast
- Conventional
- Market Size & Forecast
- Daily
- Market Size & Forecast
- Introduction
- Product Overview
- Introduction
- Market Size & Forecast
- Equipment
- Market Size & Forecast
- Service
- Market Size & Forecast
- Introduction
- Regional Overview
- Introduction
- Market Size & Forecast
- America
- North America
- U.S.
- By Type
- By Product
- Canada
- By Type
- By Product
- Mexico
- By Type
- By Product
- Latin America
- By Type
- By Product
- Europe
- Market Size & Forecast
- Germany
- By Type
- By Product
- France
- By Type
- By Product
- U.K.
- By Type
- By Product
- Italy
- By Type
- By Product
- Spain
- By Type
- By Product
- Rest of Europe
- By Type
- By Product
- Asia Pacific
- Market Size & Forecast
- Japan
- By Type
- By Product
- China
- By Type
- By Product
- Australia
- By Type
- By Product
- India
- By Type
- By Product
- South Korea
- By Type
- By Product
- Rest of Asia-Pacific
- By Type
- By Product
- Middle East & Africa
- Market Size & Forecast
- Saudi Arabia
- By Type
- By Product
- South Africa
- By Type
- By Product
- Kuwait
- By Type
- By Product
- Rest of Middle East & Africa
- By Type
- By Product
- Introduction
- Company Profile
- Asahi Kasei Corporation
- Company Overview
- Financial Performance
- Recent Developments
- Product Portfolio
- B. Braun Melsungen AG
- Company Overview
- Financial Performance
- Recent Developments
- Product Portfolio
- Baxter International Inc
- Company Overview
- Financial Performance
- Recent Developments
- Product Portfolio
- Asahi Kasei Corporation
- Conclusion & Recommendation
- Acronyms & Abbreviations
Table of Content and Figure @ https://straitsresearch.com/report/hemodialysis-market/toc
Market News:
- In March 2022, Nipro Medical Corporation introduced the SURDIAL DX Hemodialysis System in the USA. The system is designed to provide patients and clinicians with an optimal dialysis treatment experience.
- In January 2022, NextKidney acquired Dialysis in order to accelerate the development of its portable Neokidney hemodialysis system.
News Media
North America to Dominate the Renal Replacement Therapy Market
Increasing Prevalence of Chronic Kidney Diseases Globally to Support Growth of Hemodialysis Market
Have a Look at the Related Research Report
Dialysis Market: Information by Type (Hemodialysis, Peritoneal Dialysis), Product and Service (Equipment, Consumables), End-User (Dialysis, Home Dialysis), and Region — Forecast till 2030
Home Dialysis Systems Market: Introduction by Type (Hemodialysis, Peritoneal Dialysis), Product (Device, Consumables), and Region — Forecast till 2030
Dialysis Machine Market: Information by Product (Hemodialysis Equipment, Peritoneal Dialysis Equipment), End-User (Hospitals, Dialysis Centers), and Region— Forecast till 2029
About Straits Research Pvt. Ltd.
StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
For more information on your target market, please contact us below:
Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)
Email: sales@straitsresearch.com
Follow Us: LinkedIn | Facebook | Instagram | Twitter
![](https://ml.globenewswire.com/media/ZWViYzM0MDktNzYyYi00MTU1LWExNDItYjE0ZmJlZGQzMjZjLTEyMjA2Nzk=/tiny/Straits-Research.png)